1. No category

A) Estudios y Evidencias en el uso de Cannabis y su regulación en la cual se sustenta el contenido
del video.
1. “Completo meta-análisis realizado por International Centre for Science and Drug Policy
sobre estado de la evidencia en uso de cannabis y regulación”
Dan Werb, Tara Marie Watson, Naslee Maghsoudi, Estado de evidencia del uso de
Cannabis, 2015, International Centre for Science and Drug Policy.
2. “ Científicos británicos demuestran en una investigación que el cannabis no influye en la
capacidad intelectual de una persona, los resultados invalidan los de otro estudio
realizado hace dos años en la Universidad de Duke”
C. Mokrysz1, S. Gage, R. Landy, M.R. Munaf`o, J.P. Roiser, H.V. Curran ,
Neuropsychological and educational outcomes related to adolescent cannabis use, a
prospective cohort study, 2014, European College of Neuropsychopharmacology,
University College London, Clinical Psychopharmacology Unit, London, United Kingdom;
University of Bristol, School of Social and Community Medicine, Bristol, United Kingdom;
Wolfson Institute of reventive Medicine, Centre for Cancer Prevention, London, United
Kingdom; University of Bristol, School of experimental Psychology, Bristol, United
Kingdom; University College London, Institute of cognitive Neuroscience, London, United
Kingdom.
3. “Estudio muestra que consume de cannabis en adolescentes no está relacionado con un
menor Coeficiente Intelectual.”
Ole Rogeberg, Correlations between cannabis use and IQ change in the Dunedin cohort
are consistent with confounding from socioeconomic status, The Ragnar Frisch Centre for
Economic Research, 2012, Edited by Leslie Lars Iversen, University of Oxford, Oxford,
United Kingdom.
4. “Uso de cannabis no está asociado con cambios morfológicos en el cerebro de jóvenes y
adultos”
Barbara J. Weiland, Rachel E. Thayer,Brendan E. Depue, Amithrupa Sabbineni, Angela D.
Bryan, and Kent E. Hutchison, Daily Marijuana Use Is Not Associated with Brain
Morphometric Measures in Adolescents or Adults, 2015, Department of Psychology and
neuroscience, University of Colorado Boulder, and Department of Psychological and Brain
Sciences, University of Louisville, Louisville.
5. “Estudio de Harvard muestra que no hay relación de causalidad entre uso de cannabis y
esquizofrenia o eventos psicóticos”
Ashley C. Proal, Jerry Fleming, Juan A. Galvez-Buccollini, and Lynn E. DeLisi, A Controlled
Family Study of Cannabis Users with and without Psychosis, 2015, Harvard Medical
School, Boston, Veterans Administration Boston Healthcare System, Brockton, MA.
6. “Estudio compara el riesgo de alcohol, tabaco y cannabis para la salud: los dos primeros
implican un riesgo muy superior al del cannabis”
Dirk W. Lachenmeier, Jurgen Rehm, Comparative risk assessment of alcohol, tobacco,
cannabis and other illicit drugs using the margin of exposure approach, 2015,
Epidemiological Research Unit, Technische Universita Dresden, Klinische Psychologie &
Psychotherapie, Dresden, Germany, Chemisches und Veterinaruntersuchungsamt,
Germany, Social and Epidemiological Research Department, Centre for Addiction and
Mental Health, Toronto, Canada, Institute of Medical Sciences, University of Toronto,
Toronto, Canada, Dalla Lana School of Public Health, Toronto, Canada, Dept. of Psychiatry,
Faculty of Medicine, Toronto, Canada, WHO Collaborating Centre for Mental Health &
Addiction, Toronto, Canada.
7. “El uso de marihuana en adolescentes no está vinculado a depresión, cáncer de pulmón u
otros problemas de salud”.
Jordan Bechtold, Theresa Simpson, Helene R. White, Dustin Pardini, Chronic Adolescent
Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult
Men, 2015, University of Pittsburgh School of Medicine, Rutgers University, University of
Pittsburgh Medical Center.
8. “La droga de inicio es el alcohol y no el cannabis”
Kirby T, Barry AE. Alcohol as a gateway drug: a study of US 12th graders. Journal School of
Health, American School Health Association, 2012; 82: 371-379.
9. “El uso de cannabis no aumenta debido a la regulación”
Substance Abuse and Mental Health Services Administration, Results from the 2013
National Survey on Drug Use and Health: Summary of National Findings: Substance
Abuse and Mental Health Services, 2014.
B) Estudios y evidencia sobre uso medicinal del Cannabis en los que se sustentan el contenido
del video.
1. Base de datos de estudios y casos clínicos. 2011, International Association for
Cannabinoid Medicines.
2. J. Michael Bostwick , Blurred Boundaries: The Therapeutics and Politics of Medical
Marijuana, 2012, Mayo Clinic.
3. Mark A Ware, Dra. Julie Desroches, Cannabis medicinal y Dolor, International Association
for the study of pain, 2014, Pain Management Unit McGill University Health Centre,
Montreal (Quebec) Canadá, , Faculty of Medicine Université de Montréal.
4.
-
Daniel Friedman, Orrin Devinsky, Cannabinoids in the Treatment of Epilepsy,
Department
of Neurology, New York University Langone School of Medicine, New
York, 2015, The new
england journal of medicine.
-
Shaun A. Hussain ⁎, Raymond Zhou, Catherine Jacobson, Julius Weng, Emily Cheng,
Johnson Lay, Phoebe Hung, Jason T. Lerner, Raman Sankar, Perceived efficacy of
cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A
potential role for infantile spasms and Lennox–Gastaut syndrome Division of Pediatric
Neurology, Mattel Children's Hospital at UCLA, David Geffen School of Medicine, Los
Angeles, CA, USA.
5. “En un 25% han bajado las muertes por sobredosis de analgésicos de origen opioide en los
estados que han legalizado el cannabis medicinal “
Marcus A. Bachhuber; Brendan Saloner; Chinazo O. Cunningham, Colleen L. Barry, Medical
Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010.